跳至主要内容
临床试验/NCT02476643
NCT02476643Unknown不适用

Integrative Therapy in Gastroenterology - a Prospective Observational Trial in a Department of Internal and Integrative Medicine

Universität Duisburg-Essen1 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2015年10月最近更新:
适应症

试验速览

阶段
不适用
入组人数
200
试验地点
1
主要终点
Symptoms Severity CAI

研究概览

简要总结

This study aims to test, if a two-week integrative therapy in an internal medicine ward will improve symptoms, disability and quality of life in patients with inflammatory bowel disease or irritable bowel syndrome.a It shall further be tested, if those changes are associated with attitudes and experiences towards complementary and alternative medicine, anxiety, depression and stress perception as well as body awareness and responsiveness.

详细描述

see above

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 18 years or older
  • diagnosed with Irritable Bowel Syndrome (IBS) or Inflammatory Bowel Disease (IBD)
  • written informed consent

排除标准

  • participation in other clinical studies

结局指标

主要结局

Symptoms Severity CAI

时间窗: 2 weeks

Symptoms Severity assessed by Clinical Activity Index (CAI) (Rachmilewitz 1989)

Symptoms Severity CDAI

时间窗: 2 weeks

Symptoms Severity assessed by Crohn Disease Activity Index (CDAI)

Symptoms Severity IBS-SSS

时间窗: 2 weeks

Symptoms Severity assessed by Irritable Bowel Syndrome Symptom Severity Score (IBS-SSS) (Francis, 1997)

次要结局

  • Disability MYMOP(24 weeks)
  • Symptoms Severity CDAI(24 weeks)
  • Quality of Life IBS-QOL(24 weeks)
  • Body awareness BAQ(24 weeks)
  • Body awareness BRS(24 weeks)
  • Symptoms Severity IBS-SSS(24 weeks)
  • Adverse effects(2 weeks)
  • Symptoms Severity CAI(24 weeks)
  • Quality of Life IBDQ(24 weeks)
  • Self efficacy questionnaire SWE(24 weeks)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Romy Lauche

Principal Investigator

Universität Duisburg-Essen

研究点 (1)

Loading locations...

相似试验